 |
|
Efficacy of Intravitreal Triamcinolone Acetonide for Eyes with Postvitrectomy Diabetic Vitreous Hemorrhage
Sun Young Lee, Hee Gyung Lee, Hye-won Chung, Young Hee Yoon, June-Gone Kim
Korean J Ophthalmol. 2007;21(4):208-212. Published online 2007 Dec 20 DOI: https://doi.org/10.3341/kjo.2007.21.4.208
|
|
Citations to this article as recorded by
 Long-term outcomes of administration of intravitreal triamcinolone acetonide after posterior vitreous detachment during pars plana vitrectomy for proliferative diabetic retinopathy
Mengyu Liao, Yunli Huang, Jiaxing Wang, Xiangda Meng, Yuanyuan Liu, Jinguo Yu, Hua Yan
British Journal of Ophthalmology.2023; 107(4): 560. CrossRef Role of residual vitreous cortex removal in prevention of postoperative vitreous hemorrhage in diabetic vitrectomy
Rizwan A. Cheema, Javed Mushtaq, Maheera A. Cheema
International Ophthalmology.2010; 30(2): 137. CrossRef Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study
Dong Ho Park, Jae Pil Shin, Si Yeol Kim
Graefe's Archive for Clinical and Experimental Ophthalmology.2010; 248(5): 641. CrossRef Ultrasonographic Pictures of Intravitreal Triamcinolone Acetonide
Hamid Hosseini, Hamid R. Anvari-Ardakani, Mohammad A. Karanjam, Mohsen Farvardin, Sarah Nowroozizadeh
European Journal of Ophthalmology.2009; 19(2): 263. CrossRef
|